Detalles de la búsqueda
1.
Development of a population pharmacokinetic model for the novel long-acting injectable antipsychotic risperidone ISM®.
Br J Clin Pharmacol
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38866397
2.
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes.
J Antimicrob Chemother
; 68(9): 1994-2002, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23629015
3.
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.
BMC Infect Dis
; 13: 382, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23961924
4.
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.
Neuropsychiatr Dis Treat
; 19: 219-232, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721796
5.
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.
Retrovirology
; 9: 68, 2012 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22889300
6.
Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study.
Schizophr Res
; 239: 83-91, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34847501
7.
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study.
Drug Des Devel Ther
; 15: 4371-4382, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34703212
8.
Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy.
Antimicrob Agents Chemother
; 54(7): 3018-20, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20479204
9.
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.
AIDS Rev
; 11(1): 39-51, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19290033
10.
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.
Antimicrob Agents Chemother
; 53(10): 4153-8, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19596874
11.
[Viral resistance and genetic barrier of atazanavir]. / Resistencia viral y barrera genética de atazanavir.
Enferm Infecc Microbiol Clin
; 26 Suppl 17: 28-33, 2008 Dec.
Artículo
en Español
| MEDLINE | ID: mdl-20116614
12.
A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia.
Int Clin Psychopharmacol
; 33(2): 79-87, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29112001
13.
Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91].
Schizophr Res
; 246: 258-259, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853294
14.
Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1).
Int Clin Psychopharmacol
; 31(6): 323-31, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27416102
15.
Newer Formulations of Risperidone: Remarks About Risperidone ISM®.
CNS Drugs
; 34(10): 1087-1088, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892315
16.
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies.
AIDS
; 27(1): 81-5, 2013 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22842995
17.
Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection.
Expert Opin Pharmacother
; 13(7): 1007-14, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22519768
18.
Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain.
AIDS Res Hum Retroviruses
; 27(6): 633-8, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21039316
19.
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.
AIDS
; 24(3): 469-71, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20057310
20.
Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
AIDS Res Hum Retroviruses
; 25(10): 967-72, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19842792